These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33549914)

  • 1. Point of view: Wearable systems for at-home monitoring of motor complications in Parkinson's disease should deliver clinically actionable information.
    Ghoraani B; Galvin JE; Jimenez-Shahed J
    Parkinsonism Relat Disord; 2021 Mar; 84():35-39. PubMed ID: 33549914
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to "Comment on: "Point of view: Wearable systems for at-home monitoring of motor complications in Parkinson's disease should deliver clinically actionable information".
    Ghoraani B; Galvin JE; Jimenez-Shahed J
    Parkinsonism Relat Disord; 2021 May; 86():134. PubMed ID: 33896690
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on: "Point of view: Wearable systems for at-home monitoring of motor complications in Parkinson's disease should deliver clinically actionable information".
    Artusi CA; Espay AJ
    Parkinsonism Relat Disord; 2021 May; 86():133. PubMed ID: 33896689
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous quantitative monitoring of physical activity in Parkinson's disease patients by using wearable devices: a case-control study.
    Cai G; Huang Y; Luo S; Lin Z; Dai H; Ye Q
    Neurol Sci; 2017 Sep; 38(9):1657-1663. PubMed ID: 28660562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Sensor and Wearable Technologies to Aid in the Diagnosis and Treatment Monitoring of Parkinson's Disease.
    Monje MHG; Foffani G; Obeso J; Sánchez-Ferro Á
    Annu Rev Biomed Eng; 2019 Jun; 21():111-143. PubMed ID: 31167102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in sensor and wearable technologies for Parkinson's disease.
    Sánchez-Ferro Á; Maetzler W
    Mov Disord; 2016 Sep; 31(9):1257. PubMed ID: 27477675
    [No Abstract]   [Full Text] [Related]  

  • 7. Towards remote monitoring of Parkinson's disease tremor using wearable motion capture systems.
    Delrobaei M; Memar S; Pieterman M; Stratton TW; McIsaac K; Jog M
    J Neurol Sci; 2018 Jan; 384():38-45. PubMed ID: 29249375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing subjective and objective response to medications in Parkinson's disease patients using the Personal KinetiGraph™.
    Krause E; Randhawa J; Mehanna R
    Parkinsonism Relat Disord; 2021 Jun; 87():105-110. PubMed ID: 34020301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limb and trunk accelerometer data collected with wearable sensors from subjects with Parkinson's disease.
    Vergara-Diaz G; Daneault JF; Parisi F; Admati C; Alfonso C; Bertoli M; Bonizzoni E; Carvalho GF; Costante G; Fabara EE; Fixler N; Golabchi FN; Growdon J; Sapienza S; Snyder P; Shpigelman S; Sudarsky L; Daeschler M; Bataille L; Sieberts SK; Omberg L; Moore S; Bonato P
    Sci Data; 2021 Feb; 8(1):47. PubMed ID: 33547317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative Evaluation of the Personal KinetiGraphTM Movement Recording System in a Parkinson's Clinic.
    Santiago A; Langston JW; Gandhy R; Dhall R; Brillman S; Rees L; Barlow C
    J Parkinsons Dis; 2019; 9(1):207-219. PubMed ID: 30412506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)Deprenyl (selegiline) in Parkinson's disease: a pharmacologist's comment.
    Knoll J
    Biomed Pharmacother; 1996; 50(6-7):315-7. PubMed ID: 8952875
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experience.
    Thomas I; Alam M; Bergquist F; Johansson D; Memedi M; Nyholm D; Westin J
    J Neurol; 2019 Mar; 266(3):651-658. PubMed ID: 30659356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory surface electromyography with accelerometry for evaluating daily motor fluctuations in Parkinson's disease.
    Rissanen SM; Koivu M; Hartikainen P; Pekkonen E
    Clin Neurophysiol; 2021 Feb; 132(2):469-479. PubMed ID: 33450567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of home-based automated Parkinson's disease motor assessment.
    Mera TO; Heldman DA; Espay AJ; Payne M; Giuffrida JP
    J Neurosci Methods; 2012 Jan; 203(1):152-6. PubMed ID: 21978487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive, personalized closed-loop therapy for Parkinson's disease: biochemical, neurophysiological, and wearable sensing systems.
    di Biase L; Tinkhauser G; Martin Moraud E; Caminiti ML; Pecoraro PM; Di Lazzaro V
    Expert Rev Neurother; 2021 Dec; 21(12):1371-1388. PubMed ID: 34736368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated Systems Based on Wearable Sensors for the Management of Parkinson's Disease at Home: A Systematic Review.
    Rovini E; Maremmani C; Cavallo F
    Telemed J E Health; 2019 Mar; 25(3):167-183. PubMed ID: 29969384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled levodopa (Inbrija) for Parkinson's disease.
    Med Lett Drugs Ther; 2019 May; 61(1572):73-74. PubMed ID: 31169799
    [No Abstract]   [Full Text] [Related]  

  • 18. Walking while talking: a dopamine-responsive task in early Parkinson's disease.
    Kwon PS; Verghese J
    J Am Geriatr Soc; 2005 Apr; 53(4):735-7. PubMed ID: 15817033
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Parkinson's disease should begin with a dopamine agonist.
    Montastruc JL
    Mov Disord; 2000 Mar; 15(2):361-2. PubMed ID: 10752600
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Parkinson's disease.
    Calne DB
    N Engl J Med; 1993 Sep; 329(14):1021-7. PubMed ID: 8366903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.